175 related articles for article (PubMed ID: 11703667)
1. Cas1p is a membrane protein necessary for the O-acetylation of the Cryptococcus neoformans capsular polysaccharide.
Janbon G; Himmelreich U; Moyrand F; Improvisi L; Dromer F
Mol Microbiol; 2001 Oct; 42(2):453-67. PubMed ID: 11703667
[TBL] [Abstract][Full Text] [Related]
2. Isolation and characterization of capsule structure mutant strains of Cryptococcus neoformans.
Moyrand F; Klaproth B; Himmelreich U; Dromer F; Janbon G
Mol Microbiol; 2002 Aug; 45(3):837-49. PubMed ID: 12139628
[TBL] [Abstract][Full Text] [Related]
3. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans.
McFadden DC; Casadevall A
J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170
[TBL] [Abstract][Full Text] [Related]
4. CPS1, a homolog of the Streptococcus pneumoniae type 3 polysaccharide synthase gene, is important for the pathobiology of Cryptococcus neoformans.
Chang YC; Jong A; Huang S; Zerfas P; Kwon-Chung KJ
Infect Immun; 2006 Jul; 74(7):3930-8. PubMed ID: 16790766
[TBL] [Abstract][Full Text] [Related]
5. Toward an integrated model of capsule regulation in Cryptococcus neoformans.
Haynes BC; Skowyra ML; Spencer SJ; Gish SR; Williams M; Held EP; Brent MR; Doering TL
PLoS Pathog; 2011 Dec; 7(12):e1002411. PubMed ID: 22174677
[TBL] [Abstract][Full Text] [Related]
6. Role for Golgi reassembly and stacking protein (GRASP) in polysaccharide secretion and fungal virulence.
Kmetzsch L; Joffe LS; Staats CC; de Oliveira DL; Fonseca FL; Cordero RJ; Casadevall A; Nimrichter L; Schrank A; Vainstein MH; Rodrigues ML
Mol Microbiol; 2011 Jul; 81(1):206-18. PubMed ID: 21542865
[TBL] [Abstract][Full Text] [Related]
7. Parallel beta-helix proteins required for accurate capsule polysaccharide synthesis and virulence in the yeast Cryptococcus neoformans.
Liu OW; Kelly MJ; Chow ED; Madhani HD
Eukaryot Cell; 2007 Apr; 6(4):630-40. PubMed ID: 17337638
[TBL] [Abstract][Full Text] [Related]
8. Nitrogen metabolite repression of metabolism and virulence in the human fungal pathogen Cryptococcus neoformans.
Lee IR; Chow EW; Morrow CA; Djordjevic JT; Fraser JA
Genetics; 2011 Jun; 188(2):309-23. PubMed ID: 21441208
[TBL] [Abstract][Full Text] [Related]
9. The capsule of the fungal pathogen Cryptococcus neoformans.
Zaragoza O; Rodrigues ML; De Jesus M; Frases S; Dadachova E; Casadevall A
Adv Appl Microbiol; 2009; 68():133-216. PubMed ID: 19426855
[TBL] [Abstract][Full Text] [Related]
10. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans Cap70 as determined by 2D NMR spectroscopy.
Bacon BE; Cherniak R; Kwon-Chung KJ; Jacobson ES
Carbohydr Res; 1996 Mar; 283():95-110. PubMed ID: 8901265
[TBL] [Abstract][Full Text] [Related]
11. Cas3p belongs to a seven-member family of capsule structure designer proteins.
Moyrand F; Chang YC; Himmelreich U; Kwon-Chung KJ; Janbon G
Eukaryot Cell; 2004 Dec; 3(6):1513-24. PubMed ID: 15590825
[TBL] [Abstract][Full Text] [Related]
12. Complementation of a capsule-deficient mutation of Cryptococcus neoformans restores its virulence.
Chang YC; Kwon-Chung KJ
Mol Cell Biol; 1994 Jul; 14(7):4912-9. PubMed ID: 8007987
[TBL] [Abstract][Full Text] [Related]
13. Structure of the O-deacetylated glucuronoxylomannan from Cryptococcus neoformans serotype C as determined by 2D 1H NMR spectroscopy.
Bacon BE; Cherniak R
Carbohydr Res; 1995 Oct; 276(2):365-86. PubMed ID: 8542606
[TBL] [Abstract][Full Text] [Related]
14. Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans.
Otteson EW; Welch WH; Kozel TR
J Biol Chem; 1994 Jan; 269(3):1858-64. PubMed ID: 8294434
[TBL] [Abstract][Full Text] [Related]
15. Role of the Apt1 protein in polysaccharide secretion by Cryptococcus neoformans.
Rizzo J; Oliveira DL; Joffe LS; Hu G; Gazos-Lopes F; Fonseca FL; Almeida IC; Frases S; Kronstad JW; Rodrigues ML
Eukaryot Cell; 2014 Jun; 13(6):715-26. PubMed ID: 24337112
[TBL] [Abstract][Full Text] [Related]
16. Antigenic and biological characteristics of mutant strains of Cryptococcus neoformans lacking capsular O acetylation or xylosyl side chains.
Kozel TR; Levitz SM; Dromer F; Gates MA; Thorkildson P; Janbon G
Infect Immun; 2003 May; 71(5):2868-75. PubMed ID: 12704160
[TBL] [Abstract][Full Text] [Related]
17. Systematic capsule gene disruption reveals the central role of galactose metabolism on Cryptococcus neoformans virulence.
Moyrand F; Fontaine T; Janbon G
Mol Microbiol; 2007 May; 64(3):771-81. PubMed ID: 17462022
[TBL] [Abstract][Full Text] [Related]
18. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library.
Beenhouwer DO; May RJ; Valadon P; Scharff MD
J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134
[TBL] [Abstract][Full Text] [Related]
19. Production of extracellular polysaccharides by CAP mutants of Cryptococcus neoformans.
Grijpstra J; Gerwig GJ; Wösten H; Kamerling JP; de Cock H
Eukaryot Cell; 2009 Aug; 8(8):1165-73. PubMed ID: 19542308
[TBL] [Abstract][Full Text] [Related]
20. Capsule structural heterogeneity and antigenic variation in Cryptococcus neoformans.
McFadden DC; Fries BC; Wang F; Casadevall A
Eukaryot Cell; 2007 Aug; 6(8):1464-73. PubMed ID: 17601878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
